21st Century Treatment of Heart Failure
InterContinental Hotel & Bank of America Conference Center
9801 Carnegie Ave. Cleveland, Ohio 44106
Cleveland , Ohio
The Kaufman Center for Heart Failure at Cleveland Clinic and the American Association for Thoracic Surgery (AATS) are pleased to provide an educational event for all health care providers who specialize in the treatment of heart failure; 21st Century Treatment of Heart Failure: Synchronizing Surgical and Medical Therapies for Better Outcomes.  Two of America’s leading cardiovascular specialty organizations have come together to address the growing problem of heart failure and together they offer the most advanced review of the current and future medical and surgical treatments for this disease.

Schedule of Presentations:

Thursday, October 21, 2010
07:55:00 Welcome and Announcements
08:00:00 Session I: Contemporary Issues in Heart Failure Management Randall C. Starling
08:05:00 Quality and Outcomes Data in Heart Failure Clyde W. Yancy
08:20:00 Expanding Indications for CRT: Putting MADIT-CRT into the Context of Heart Failure Practice Bruce D. Lindsay
08:40:00 Risk Stratification in Heart Failure Using Novel Imaging Techniques Thomas Marwick
09:00:00 The Evolution of MCS over the Past 30 Years Walter E. Pae
09:20:00 Are We Ready for LVADS in Class III Patients? Joseph Rogers
09:40:00 Panel Discussion
10:00:00 Break
10:25:00 Session II: Contemporary Issues in Heart Failure Management Christine S. Moravec
10:30:00 Registries and Guidelines: Have They Helped Us Provide Better Patient Care in the Real World? Eiran Gorodeski
10:50:00 Addressing Anemia in Heart Failure: What Have We Learned? W.H. Wilson Tang
11:10:00 New Insights into the Cardiorenal Syndrome A Costanzo
11:30:00 Vasodilators in the Setting of ADHF John R. Teerlink
11:50:00 Panel Discussion
12:10:00 Lunch
13:10:00 Session III: Kaufman Center Award and Lecture Randall C. Starling
13:15:00 Lecture by James B. Young James B. Young
13:40:00 Session IV: Clinical Trials of Drugs and Devices for Heart Failure James B. Young
13:45:00 Will Clinical Site Research Survive in the U.S. and Can We Afford It? Robert M. Califf
14:05:00 The STICH Trial: What Went Wrong, What Went Right? John V. Conte
14:25:00 Are the Patients We Study Those We Treat? Clyde W. Yancy
14:45:00 The Economics of Developing New Drugs and Devices: Is the Pipeline for New Drugs “Drying Up”? Steven E Nissen
15:05:00 Harmonization of LVAD Trials Around the World Eric Chen
15:25:00 Panel Discussion
15:40:00 Session V: Update on the Medical and Surgical Management of Ischemic Cardiomyopathy Soon J Park
15:45:00 State of the Art Cardiac Regeneration with Stem Cells Marc S. Penn
16:05:00 Ventricular Reconstruction: Indications, Physiologic Impact, Surgical Techniques, and Outcomes Robert A.E. Dion
16:25:00 The Treatment of Ischemic Mitral Valve Disease:
16:30:00 Imaging Robert A. Levine
16:45:00 Repair Tomislav Mihaljevic
17:00:00 Panel Discussion
17:30:00 Poster Presentations / Attendee Reception / Exhibits
Friday, October 22, 2010
07:55:00 Session VI: Mechanical Circulatory Support and Transplant: Patient Selection David O. Taylor, Nicholas G. Smedira
08:00:00 Where is the Data That Obesity is a Contraindication to Heart Transplant and MCS? David O. Taylor
08:20:00 Gastric Bypass Surgery for Heart Failure: The Impact of Weight Loss on CV Structure and Function Philip R. Schauer
08:40:00 Strategies for LVAD Therapy: Does BTT, BTC and DT Impact Management and Outcomes? Benjamin C. Sun
09:00:00 Pre-Operative Predictors of Post LVAD Mortality Leslie W. Miller
09:20:00 A Good LVAD is Better Than a Bad Transplant! George M. Wieselthaler
09:40:00 Panel Discussion
10:00:00 Break
10:15:00 Session VII: Management of the Patient on MCS in the Continuum of Care Nicholas G. Smedira, George M. Wieselthaler
10:20:00 Management of Acute Decompensated Heart Failure and Shock (Point/Counterpoint)
10:25:00 Back to the Future: ECMO Should be the First Choice Pascal N. Leprince
10:30:00 Avoid an Oxygenator At All Costs: Tandem Heart or Impella Edward Soltesz
10:40:00 Managing RV Failure (Point/Counterpoint)
10:45:00 Temporary RV Support is the Best Strategy Steven W. Boyce
10:50:00 Early Planned BiV Support Results in Improved Outcomes Michael A. Acker
11:10:00 Eliminate Drive-Line Infection Nicholas G. Smedira
11:25:00 Neurological Events: Patient? Device? Management? Maria Mountis
11:40:00 Are ICDs Beneficial in the LVAD Population Daniel J. Cantillon
11:55:00 Outpatient Management of the “Destination” Patient: Are Focused Clinics and Telemanagement the Answer? Robert L. Kormos
12:10:00 Utilizing Best Practices to Reduce Readmissions in the LVAD Population Laura D. Damme
12:25:00 Panel Discussion
12:45:00 Lunch
13:55:00 Session VIII: The Present and Future of Innovation in MCS Robert L. Kormos
14:00:00 Total Artificial Heart
14:05:00 Why I Love It Jack G. Copeland
14:20:00 Why I Hate It Gonzalo Gonzalez-Stawinski
14:40:00 Update on New Technology: Duraheart, Terumo, and Heartware Aly El-Banayosy
15:00:00 Update on New Technology: Tandem Heart, Impella, Circulite William E. Cohn
15:20:00 Maximizing Reimbursement for Innovation Robin Roberts Bostic
15:40:00 Will MCS Replace Heart Transplant in this Decade? Leonard Golding
16:00:00 Panel Discussion
16:20:00 Adjourn
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.